Skip to main content

What type of drug is Bavencio?

Medically reviewed by Leigh Ann Anderson, PharmD. Last updated on Feb 12, 2024.

Official answer


Bavencio (avelumab) is a programmed death ligand-1 (PD-L1) blocking antibody.

Bavencio targets the PD-L1 receptors, which are protein receptors on cell surfaces. When Bavencio blocks PD-L1, it 'turns on' the ability of cancer-fighting cells such as T-cells to attack and kill tumors.

Learn More: Checkpoint Inhibitors & Advanced Cancers: A Health Care Professional's Guide

Bavencio is used for the treatment of:

  • Bavencio (avelumab) [product information]. EMD Serono, Inc.
    Rockland, MA. Accessed Feb. 20, 2021 at

Related medical questions

Drug information

Related support groups